Yu Qin

887 total citations
30 papers, 678 citations indexed

About

Yu Qin is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Yu Qin has authored 30 papers receiving a total of 678 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Oncology and 7 papers in Surgery. Recurrent topics in Yu Qin's work include Cervical Cancer and HPV Research (7 papers), MicroRNA in disease regulation (6 papers) and Multiple Myeloma Research and Treatments (4 papers). Yu Qin is often cited by papers focused on Cervical Cancer and HPV Research (7 papers), MicroRNA in disease regulation (6 papers) and Multiple Myeloma Research and Treatments (4 papers). Yu Qin collaborates with scholars based in China, United States and Canada. Yu Qin's co-authors include Hongbing Shen, Yaochu Xu, Margaret R. Spitz, Yun Qian, Ling Zhou, YU Rong-bin, Xinru Wang, Wen Chen, Lulu Yu and Qingyi Wei and has published in prestigious journals such as Blood, Journal of Medicinal Chemistry and International Journal of Cancer.

In The Last Decade

Yu Qin

27 papers receiving 668 citations

Peers

Yu Qin
Yu Qin
Citations per year, relative to Yu Qin Yu Qin (= 1×) peers Slah Ouerhani

Countries citing papers authored by Yu Qin

Since Specialization
Citations

This map shows the geographic impact of Yu Qin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Qin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Qin more than expected).

Fields of papers citing papers by Yu Qin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Qin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Qin. The network helps show where Yu Qin may publish in the future.

Co-authorship network of co-authors of Yu Qin

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Qin. A scholar is included among the top collaborators of Yu Qin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Qin. Yu Qin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qin, Yu, Xiaofei Qi, Qian Huang, et al.. (2025). Radio-magnetic dual-functional microspheres for magnetic hyperthermia therapy combined with radioembolization of hepatocellular carcinoma. Materials Today Bio. 35. 102553–102553.
2.
Yong, Wei Peng, Shu Zhang, Yu Qin, et al.. (2025). Click Covalent-Targeted Radionuclide Therapy for Prostate Cancer. Journal of Medicinal Chemistry. 68(16). 17794–17807.
3.
Wan, Dan, et al.. (2021). 14-3-3ζ promoted invasion and lymph node metastasis of breast invasive ductal carcinoma with HER2 overexpression. Pathology - Research and Practice. 227. 153619–153619.
4.
Niu, Kaijun, Xiewan Chen, Yu Qin, et al.. (2021). Celecoxib Blocks Vasculogenic Mimicry via an Off-Target Effect to Radiosensitize Lung Cancer Cells: An Experimental Study. Frontiers in Oncology. 11. 697227–697227. 10 indexed citations
5.
Huo, Qianyu, et al.. (2021). Free CA125 promotes ovarian cancer cell migration and tumor metastasis by binding Mesothelin to reduce DKK1 expression and activate the SGK3/FOXO3 pathway. International Journal of Biological Sciences. 17(2). 574–588. 27 indexed citations
6.
Yu, Ge, Yi Pan, Xiaoling Du, et al.. (2021). Antitumor Effect of Lenvatinib Combined with Alisertib in Hepatocellular Carcinoma by Targeting the DNA Damage Pathway. BioMed Research International. 2021(1). 6613439–6613439. 5 indexed citations
7.
Li, Tingyuan, Zeni Wu, Mingyue Jiang, et al.. (2020). Clinical performance of Onclarity HPV assay and Cobas HPV test in detection of cervical precancer and cancer in Chinese women. Gynecologic Oncology. 157(1). 202–208. 5 indexed citations
8.
Wu, Zeni, Lulu Yu, Yu Qin, et al.. (2018). The association between human papillomavirus 16, 18 DNA load and E6 protein expression in cervical intraepithelial neoplasia and cancer. Journal of Clinical Virology. 108. 6–11. 8 indexed citations
9.
Shen, Yali, et al.. (2017). Pharmacokinetics of dimemorfan phosphate tablets in healthy Chinese volunteers. European Journal of Clinical Pharmacology. 73(6). 709–715. 3 indexed citations
10.
Qin, Yu, Simin Zhang, Shuhui Deng, et al.. (2016). Epigenetic silencing of miR-137 induces drug resistance and chromosomal instability by targeting AURKA in multiple myeloma. Leukemia. 31(5). 1123–1135. 64 indexed citations
11.
Zhang, Rong, Yu Qin, Guangwei Zhu, Yali Li, & Jie Xue. (2016). Low serum miR-320b expression as a novel indicator of carotid atherosclerosis. Journal of Clinical Neuroscience. 33. 252–258. 29 indexed citations
12.
Qin, Yu, Hongyun Zhang, Natalia Marlowe, et al.. (2016). Evaluation of human papillomavirus detection by Abbott m2000 system on samples collected by FTA Elute™ Card in a Chinese HIV-1 positive population. Journal of Clinical Virology. 85. 80–85. 11 indexed citations
13.
Yu, Lulu, Huiqin Guo, Yu Qin, et al.. (2016). p16/Ki-67 co-expression associates high risk human papillomavirus persistence and cervical histopathology: a 3-year cohort study in China. Oncotarget. 7(40). 64810–64819. 17 indexed citations
14.
Hao, Mu, Meirong Zang, Yan Xu, et al.. (2015). Serum High Expression of Micorna-214 Is a Novel Predictor for Myeloma Bone Disease and Poor Prognosis. Blood. 126(23). 4186–4186. 2 indexed citations
15.
Qin, Yu, Huijing Bao, Yi Pan, et al.. (2014). SUMOylation alterations are associated with multidrug resistance in hepatocellular carcinoma. Molecular Medicine Reports. 9(3). 877–881. 28 indexed citations
16.
An, Gang, Huijun Wang, Xiaoqi Qin, et al.. (2014). Polyclonal serum IgM level identifies a subgroup of multiple myeloma patients with low-risk clinicobiological features and superior survival. Leukemia Research. 38(6). 666–672. 1 indexed citations
17.
Zhao, Xianlin, Xiang Jin, Meihua Wan, et al.. (2012). Effect of acute pancreatitis on the pharmacokinetics of Chinese herbal ointment Liu-He-Dan in anaesthetized rats. Journal of Ethnopharmacology. 145(1). 94–99. 9 indexed citations
18.
Qin, Yu. (2006). Determination of rizatriptan in human plasma by RP-HPLC with fluorescence detection. Yaowu fenxi zazhi. 4 indexed citations
19.
Shen, Hongbing, Yaochu Xu, Yuxin Zheng, et al.. (2001). Polymorphisms of 5,10-methylenetetrahydrofolate reductase and risk of gastric cancer in a Chinese population: A case-control study. International Journal of Cancer. 95(5). 332–336. 121 indexed citations
20.
Shen, Hongbing, Yaochu Xu, Yun Qian, et al.. (2000). Polymorphisms of the DNA repair geneXRCC1 and risk of gastric cancer in a Chinese population. International Journal of Cancer. 88(4). 601–606. 173 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026